Sort
64,565 grants matching “drug discovery”
The Role of B cells in the Origin and Progression of Multiple Sclerosis
$1,129,237Stephen L Hauser · University Of California, San Francisco · R35 · FY2023 · NS
Targeted Discovery of Marine-derived Anticancer Leads
$1,128,979Phil Crews · University Of California Santa Cruz · U19 · FY2006 · CA
Development of Gene-Silencing Therapeutics for Pseudomonas aeruginosa
$1,128,851David Elihu Greenberg · Ut Southwestern Medical Center · R01 · FY2020 · AI
Small-molecule inhibitors of flavivirus entry
$1,128,723Priscilla Li-Ning Yang · Harvard Medical School · U19 · FY2015 · AI
Solvation modeling for next-gen biomolecule simulations
$1,128,699Kenneth A Dill · State University New York Stony Brook · RM1 · FY2021 · GM
CMG2 as a target for safe and effective treatment of endometriosis-associate pain
$1,128,672Michael Sean Rogers · Boston Children'S Hospital · R01 · FY2025 · HD
Emory-GSK-NIMH Collaborative Mood Disorders Initiative
$1,128,476Charles B Nemeroff · Emory University · U19 · FY2006 · MH
Technology to Unmask Accessible Tumor Vascular Targets
$1,128,364Sidney Kimmel Cancer Center · R33 · FY2002 · CA
Center for Interventional Oncology
$1,128,299Bradford J Wood · Division Of Basic Sciences - Nci · ZID · FY2016 · CA
Coordinating Center for the Drug Induced Liver Injury Network (DILIN)
$1,128,182Huiman X Barnhart · Duke University · U24 · FY2019 · DK
Targeting Epigenetic Circuits in B-Cell Lymphomas
$1,128,045Ari M. Melnick · Weill Medical Coll Of Cornell Univ · R35 · FY2020 · CA
The PIP2-virus interface and PI 4-kinase: novel biology and validation targets
$1,127,800Jeffrey S Glenn · Stanford University · R01 · FY2012 · AI
Macrophages in Cardiovascular Health
$1,127,798Matthias Nahrendorf · Massachusetts General Hospital · R35 · FY2025 · HL
The MetaCyc and BioCyc Pathway/Genome Databases
$1,127,776Peter D Karp · Sri International · R01 · FY2008 · GM
The MetaCyc and BioCyc Pathway/Genome Databases
$1,127,776Peter D Karp · Sri International · R01 · FY2009 · GM
Biomarker Signatures of TB Infection in Young Children With and Without HIV
$1,127,706Padmini Salgame · Rutgers Biomedical And Health Sciences · R01 · FY2023 · AI
DCTD Human Toxicology and Pharmacology
$1,127,454David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2016 · CA
Cancer Risk in Human Populations
$1,126,839Debra Silverman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2022 · CA
Bloomington Drosophila Stock Center at Indiana University
$1,126,777Kevin R Cook · Trustees Of Indiana University · P40 · FY2024 · OD
Epigenomics of T cells and innate immune cells in human asthma
$1,126,630Anjana Rao · La Jolla Institute For Immunology · R01 · FY2011 · HL
Development of an iPSC-derived human hepatocyte platform for drug development.
$1,126,573Brian Robert Wamhoff · Hemoshear Therapeutics, Llc · R44 · FY2015 · GM
Development of a DIVI platform for issue resolution in pre-clinical drug development.
$1,126,395Brian Robert Wamhoff · Hemoshear Therapeutics, Llc · R44 · FY2015 · GM
CONTROLLED RELEASE POLYMERS FOR BRAIN TUMORS (U19 CA 528
$1,125,634Johns Hopkins University · U19 · FY2001 · CA
Development of Gene-Silencing Therapeutics for Pseudomonas aeruginosa
$1,125,531David Elihu Greenberg · Ut Southwestern Medical Center · R01 · FY2023 · AI
A 3D IN VITRO DISEASE MODEL OF ATRIAL CONDUCTION
$1,125,092Steven Carl George · University Of California At Davis · UH3 · FY2019 · HL